IFIH1 and juvenile dermatomyositis: Thus, a major difference between the juvenile form and the adult form of the disease in Caucasian patients is observed in terms of outcome, since anti-MDA5 JDM has comparable outcome with the other forms of JDM, but flares are less frequent in this subset of JDM and necessitates less medication (58, 59, 61).